Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors

P. Michal, EE. El-Fakahany, V. Doležal,

. 2015 ; 40 (10) : 2068-77. [pub] 20140513

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028545
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do 2017-12-31
Medline Complete (EBSCOhost) od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do 2017-12-31

We have found earlier that changes in membrane cholesterol content have distinct impact on signaling via the M1, M2, or M3 receptors expressed in CHO cells (CHO-M1 through CHO-M3). Now we investigated whether gradual changes in membrane cholesterol exerts differential effects on coupling of the M1 and M3 muscarinic receptors to preferential signaling pathways through Gq/11 and non-preferential Gs G-proteins signaling. Changes in membrane cholesterol resulted in only marginal alterations of antagonist and agonist affinity of the M1 and M3 receptors, and did not influence precoupling of either subtype. Changes in membrane cholesterol did not influence parameters of carbachol-stimulated GTP-γ(35)S binding in CHO-M1 membranes while reduction as well as augmentation of membrane cholesterol lowered the efficacy but increased the potency of carbachol in CHO-M3 membranes. Gradual increase or decrease in membrane cholesterol concentration dependently attenuated agonist-induced inositolphosphates release while only cholesterol depletion increased basal values in both cell lines. Similarly, membrane cholesterol manipulation modified basal and agonist-stimulated cAMP synthesis via Gs in the same way in both cell lines. These results demonstrate that changes in membrane cholesterol concentration differentially impact preferential and non-preferential M1 and M3 receptor signaling. They point to the activated G-protein/effector protein interaction as the main site of action in alterations of M1 receptor-mediated stimulation of second messenger pathways. On the other hand, modifications in agonist-stimulated GTP-γ(35)S binding in CHO-M3 membranes indicate that in this case changes in ligand-activated receptor/G-protein interaction may also play a role.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028545
003      
CZ-PrNML
005      
20161020120110.0
007      
ta
008      
161005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11064-014-1325-z $2 doi
024    7_
$a 10.1007/s11064-014-1325-z $2 doi
035    __
$a (PubMed)24821386
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Michal, Pavel $u Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, 14220, Prague, Czech Republic.
245    10
$a Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors / $c P. Michal, EE. El-Fakahany, V. Doležal,
520    9_
$a We have found earlier that changes in membrane cholesterol content have distinct impact on signaling via the M1, M2, or M3 receptors expressed in CHO cells (CHO-M1 through CHO-M3). Now we investigated whether gradual changes in membrane cholesterol exerts differential effects on coupling of the M1 and M3 muscarinic receptors to preferential signaling pathways through Gq/11 and non-preferential Gs G-proteins signaling. Changes in membrane cholesterol resulted in only marginal alterations of antagonist and agonist affinity of the M1 and M3 receptors, and did not influence precoupling of either subtype. Changes in membrane cholesterol did not influence parameters of carbachol-stimulated GTP-γ(35)S binding in CHO-M1 membranes while reduction as well as augmentation of membrane cholesterol lowered the efficacy but increased the potency of carbachol in CHO-M3 membranes. Gradual increase or decrease in membrane cholesterol concentration dependently attenuated agonist-induced inositolphosphates release while only cholesterol depletion increased basal values in both cell lines. Similarly, membrane cholesterol manipulation modified basal and agonist-stimulated cAMP synthesis via Gs in the same way in both cell lines. These results demonstrate that changes in membrane cholesterol concentration differentially impact preferential and non-preferential M1 and M3 receptor signaling. They point to the activated G-protein/effector protein interaction as the main site of action in alterations of M1 receptor-mediated stimulation of second messenger pathways. On the other hand, modifications in agonist-stimulated GTP-γ(35)S binding in CHO-M3 membranes indicate that in this case changes in ligand-activated receptor/G-protein interaction may also play a role.
650    _2
$a zvířata $7 D000818
650    _2
$a CHO buňky $7 D016466
650    _2
$a karbachol $x farmakologie $7 D002217
650    _2
$a cholesterol $x metabolismus $7 D002784
650    _2
$a Cricetulus $7 D003412
650    _2
$a proteiny vázající GTP $x metabolismus $7 D019204
650    _2
$a lidé $7 D006801
650    _2
$a receptor muskarinový M1 $x účinky léků $x metabolismus $7 D043643
650    _2
$a receptor muskarinový M3 $x účinky léků $x metabolismus $7 D043587
650    _2
$a systémy druhého messengeru $x fyziologie $7 D015290
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a El-Fakahany, Esam E $u Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, 55455, USA.
700    1_
$a Doležal, Vladimír $u Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, 14220, Prague, Czech Republic. dolezal@biomed.cas.cz.
773    0_
$w MED00003484 $t Neurochemical research $x 1573-6903 $g Roč. 40, č. 10 (2015), s. 2068-77
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24821386 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161020120518 $b ABA008
999    __
$a ok $b bmc $g 1166859 $s 953175
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 40 $c 10 $d 2068-77 $e 20140513 $i 1573-6903 $m Neurochemical research $n Neurochem Res $x MED00003484
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...